Cargando…
Hyperinsulinemic Hypoglycemia in Three Generations of a Family with Glucokinase Activating Mutation, c.295T>C (p.Trp99Arg)
Familial Hyperinsulinemic Hypoglycemia (FHH) is a very rare disease with heterogeneous clinical manifestations. There are only a few reports of heterozygous activating mutations of glucokinase (GCK) attributable to FHH, with no reports describing effects in the course in pregnancy with affected moth...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535713/ https://www.ncbi.nlm.nih.gov/pubmed/34680961 http://dx.doi.org/10.3390/genes12101566 |
_version_ | 1784587851310039040 |
---|---|
author | Gilis-Januszewska, Aleksandra Bogusławska, Anna Kowalik, Artur Rzepka, Ewelina Soczówka, Karolina Przybylik-Mazurek, Elwira Głowa, Bogusław Hubalewska-Dydejczyk, Alicja |
author_facet | Gilis-Januszewska, Aleksandra Bogusławska, Anna Kowalik, Artur Rzepka, Ewelina Soczówka, Karolina Przybylik-Mazurek, Elwira Głowa, Bogusław Hubalewska-Dydejczyk, Alicja |
author_sort | Gilis-Januszewska, Aleksandra |
collection | PubMed |
description | Familial Hyperinsulinemic Hypoglycemia (FHH) is a very rare disease with heterogeneous clinical manifestations. There are only a few reports of heterozygous activating mutations of glucokinase (GCK) attributable to FHH, with no reports describing effects in the course in pregnancy with affected mother/affected child. A large kindred with FHH and GCK:c.295T>C (p.Trp99Arg) pathogenic variant was identified in which four family members from three generations were affected. The clinical follow up in one clinical center lasted up to 30 years, with different times of diagnosis ranging from neonate period to adulthood. The severity of hypoglycemia was mild/severe and fasting was the trigger for hypoglycemia. Response to diazoxide varied from good, in the neonate, to moderate/poor, in childhood/adulthood; however, this was biased by poor compliance. Treatment with somatostatin analogues was discontinued due to side effects. Over time, patients developed clinical adaptation to very low glucose levels. During pregnancy, episodes of severe hypoglycemia in the first trimester were observed, which responded very well to steroids. The clinical course of the GCK:c.295T>C (p.Trp99Arg) mutation varied in the same family, with the development of clinical adaptation to very low glucose levels over time. Treatment with steroids might prevent hypoglycemia during pregnancy in an affected mother. |
format | Online Article Text |
id | pubmed-8535713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85357132021-10-23 Hyperinsulinemic Hypoglycemia in Three Generations of a Family with Glucokinase Activating Mutation, c.295T>C (p.Trp99Arg) Gilis-Januszewska, Aleksandra Bogusławska, Anna Kowalik, Artur Rzepka, Ewelina Soczówka, Karolina Przybylik-Mazurek, Elwira Głowa, Bogusław Hubalewska-Dydejczyk, Alicja Genes (Basel) Article Familial Hyperinsulinemic Hypoglycemia (FHH) is a very rare disease with heterogeneous clinical manifestations. There are only a few reports of heterozygous activating mutations of glucokinase (GCK) attributable to FHH, with no reports describing effects in the course in pregnancy with affected mother/affected child. A large kindred with FHH and GCK:c.295T>C (p.Trp99Arg) pathogenic variant was identified in which four family members from three generations were affected. The clinical follow up in one clinical center lasted up to 30 years, with different times of diagnosis ranging from neonate period to adulthood. The severity of hypoglycemia was mild/severe and fasting was the trigger for hypoglycemia. Response to diazoxide varied from good, in the neonate, to moderate/poor, in childhood/adulthood; however, this was biased by poor compliance. Treatment with somatostatin analogues was discontinued due to side effects. Over time, patients developed clinical adaptation to very low glucose levels. During pregnancy, episodes of severe hypoglycemia in the first trimester were observed, which responded very well to steroids. The clinical course of the GCK:c.295T>C (p.Trp99Arg) mutation varied in the same family, with the development of clinical adaptation to very low glucose levels over time. Treatment with steroids might prevent hypoglycemia during pregnancy in an affected mother. MDPI 2021-10-01 /pmc/articles/PMC8535713/ /pubmed/34680961 http://dx.doi.org/10.3390/genes12101566 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gilis-Januszewska, Aleksandra Bogusławska, Anna Kowalik, Artur Rzepka, Ewelina Soczówka, Karolina Przybylik-Mazurek, Elwira Głowa, Bogusław Hubalewska-Dydejczyk, Alicja Hyperinsulinemic Hypoglycemia in Three Generations of a Family with Glucokinase Activating Mutation, c.295T>C (p.Trp99Arg) |
title | Hyperinsulinemic Hypoglycemia in Three Generations of a Family with Glucokinase Activating Mutation, c.295T>C (p.Trp99Arg) |
title_full | Hyperinsulinemic Hypoglycemia in Three Generations of a Family with Glucokinase Activating Mutation, c.295T>C (p.Trp99Arg) |
title_fullStr | Hyperinsulinemic Hypoglycemia in Three Generations of a Family with Glucokinase Activating Mutation, c.295T>C (p.Trp99Arg) |
title_full_unstemmed | Hyperinsulinemic Hypoglycemia in Three Generations of a Family with Glucokinase Activating Mutation, c.295T>C (p.Trp99Arg) |
title_short | Hyperinsulinemic Hypoglycemia in Three Generations of a Family with Glucokinase Activating Mutation, c.295T>C (p.Trp99Arg) |
title_sort | hyperinsulinemic hypoglycemia in three generations of a family with glucokinase activating mutation, c.295t>c (p.trp99arg) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535713/ https://www.ncbi.nlm.nih.gov/pubmed/34680961 http://dx.doi.org/10.3390/genes12101566 |
work_keys_str_mv | AT gilisjanuszewskaaleksandra hyperinsulinemichypoglycemiainthreegenerationsofafamilywithglucokinaseactivatingmutationc295tcptrp99arg AT bogusławskaanna hyperinsulinemichypoglycemiainthreegenerationsofafamilywithglucokinaseactivatingmutationc295tcptrp99arg AT kowalikartur hyperinsulinemichypoglycemiainthreegenerationsofafamilywithglucokinaseactivatingmutationc295tcptrp99arg AT rzepkaewelina hyperinsulinemichypoglycemiainthreegenerationsofafamilywithglucokinaseactivatingmutationc295tcptrp99arg AT soczowkakarolina hyperinsulinemichypoglycemiainthreegenerationsofafamilywithglucokinaseactivatingmutationc295tcptrp99arg AT przybylikmazurekelwira hyperinsulinemichypoglycemiainthreegenerationsofafamilywithglucokinaseactivatingmutationc295tcptrp99arg AT głowabogusław hyperinsulinemichypoglycemiainthreegenerationsofafamilywithglucokinaseactivatingmutationc295tcptrp99arg AT hubalewskadydejczykalicja hyperinsulinemichypoglycemiainthreegenerationsofafamilywithglucokinaseactivatingmutationc295tcptrp99arg |